4
Changes in Ownership
Protagonist Therapeutics, Inc Filed Acc 0001209191-17-061002
Chief Scientific Officer sold 7,000 shares at $16.97 ($118,761)
- Chief Scientific Officer acquired 7,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Liu David Y · Chief Scientific Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-11-13 | Exercise or conversion : show line 1 in the form | +3,500 | $4.21 | $14,735 | 7,322 | D |
| 2017-11-13 | Sale : show line 2 in the form | −3,500 | $16.97 | $59,381 | 3,822 | D |
| 2017-11-13 | Exercise or conversion : show line 3 in the form | +3,500 | $1.89 | $6,615 | 7,322 | D |
| 2017-11-13 | Sale : show line 4 in the form | −3,500 | $16.97 | $59,381 | 3,822 | D |
| Open-market sales · 7,000 sh · avg $16.97 · $118,761 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-11-13 | Exercise or conversion : show line 5 in the form Employee Stock Option (right to buy) | −3,500 | 38,831 | D |
| 2017-11-13 | Exercise or conversion : show line 6 in the form Employee Stock Option (right to buy) | −3,500 | 13,225 | D |
Loading xslF345X03/doc4.xml…